Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05404867 · ClinicalTrials.gov registry record · NA
Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05404867 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 31 participants.
The verdict
NCT05404867, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will try to understand the difference in brain structure between ALS patients and healthy people of similar age. ALS is a condition affecting the nervous system with disruption of the brain networks. This study aims to understand these disruptions and determine their significance in ALS.
Interventions
- OTHER fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2024-01-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05404867
The ClinicalTrials.gov registry entry for NCT05404867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT05404867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05404867 about?
NCT05404867 is a clinical study titled "Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)". This study will try to understand the difference in brain structure between ALS patients and healthy people of similar age. ALS is a condition affecting the nervous system with disruption of the brain networks. This study aims to understand these disruptions and determine their significance in ALS.
What is the current status of trial NCT05404867?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-06-08. Estimated completion is 2024-01-08.
What interventions are being tested in trial NCT05404867?
The interventions under investigation include: fMRI (OTHER).
Who is sponsoring clinical trial NCT05404867?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.